Free tool
FAERS Monitor: Nallpen In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050655 or its brand name (Nallpen In Plastic Container, Nafcillin Sodium). Reports on generic versions are filed under their own applications.
Reports
710
Serious
618
87% of reports
Hospitalization
362
Death reported
98
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective52
- acute kidney injury48
- rash44
- tubulointerstitial nephritis39
- hypokalaemia38
- renal failure35
- renal failure acute35
- pyrexia34
- drug interaction32
- anxiety25
- drug hypersensitivity25
- nephropathy toxic24
- pain24
- blood creatinine increased23
- diarrhoea23
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 7 |
| 2005 | 11 |
| 2006 | 10 |
| 2009 | 15 |
| 2010 | 34 |
| 2011 | 33 |
| 2012 | 44 |
| 2013 | 36 |
| 2014 | 56 |
| 2015 | 35 |
| 2016 | 35 |
| 2017 | 46 |
| 2018 | 42 |
| 2019 | 59 |
| 2020 | 58 |
| 2021 | 41 |
| 2022 | 48 |
| 2023 | 40 |
| 2024 | 18 |
| 2025 | 22 |
| 2026 | 20 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,449 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| nephropathy toxicSignal | 24 | 63.5 | 42.8 | 1,412 |
| tubulointerstitial nephritisSignal | 39 | 61.8 | 45.5 | 2,269 |
| renal failure acuteSignal | 35 | 24.5 | 17.7 | 765 |
| hypokalaemiaSignal | 38 | 24.4 | 17.9 | 831 |
| blood creatinine increasedSignal | 23 | 10.4 | 7.0 | 188 |
| acute kidney injurySignal | 48 | 9.3 | 7.1 | 349 |
| renal failureSignal | 35 | 7.8 | 5.7 | 202 |
| drug interactionSignal | 32 | 6.0 | 4.3 | 129 |
| drug hypersensitivitySignal | 25 | 3.8 | 2.6 | 50 |
| rashSignal | 44 | 3.0 | 2.2 | 58 |
| pyrexiaSignal | 34 | 2.9 | 2.1 | 41 |
| anxietySignal | 25 | 2.6 | 1.8 | 23 |
| drug ineffective | 52 | 1.2 | 0.9 | 1 |
| pain | 24 | 1.2 | 0.8 | 0 |
| diarrhoea | 23 | 1.1 | 0.7 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.